Enable Life to the Better

Unimedic Group is owned by MedCap AB (publ), listed on Nasdaq Stockholm Mid Cap and the business is conducted through two different companies, Unimedic Pharma AB and Unimedic AB.

Unimedic Pharma AB register, market, and sell pharmaceuticals. The headquarters is located in Stockholm, and operations are primarily conducted in the Nordic region and northern Europe. 

Unimedic AB is a CDMO (Contract Development and Manufacturing Organization) specializing in the production and development of liquid pharmaceuticals, both sterile and non-sterile. The facility is located in Matfors, outside Sundsvall.

The contract and manufacturing organisation started in the mid-60’s as an extempore pharmacy of the time, privately owned and located in Matfors in the middle of Sweden. In the 1970’s, pharmacies were all nationalised and the laboratory in Matfors became part of ACO. In the 1980s the facility was first owned by Kabi, and later by Pharmacia. Unimedic AB was founded in 1992 when Pharmacia ceased production. Since 2006, Unimedic is a wholly owned subsidiary of MedCap AB (publ), listed on Nasdaq Stockholm Mid Cap. Today, the parent company of the group is Unimedic Pharma Holding AB; the group includes Unimedic AB and Unimedic Pharma AB. In 2019, the current group structure Unimedic Group was established.

Our vision is to enable life to the better. By developing niche pharmaceuticals for children and adults with special medical needs we strive to help them live life in better health. Further, acquisitions and long-term strategic partnerships are fundamental initiatives to continually introduce and launch new pharmaceuticals to better meet unmet medical needs. The values are the basis of our culture and provide guidance in our daily work. Our vision, mission and values, forms the backbone of the business.